Refine
Year of publication
Document Type
- Preprint (665)
- Article (386)
- Working Paper (1)
Has Fulltext
- yes (1052)
Is part of the Bibliography
- no (1052)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- SARS-CoV-2 (11)
- LHC (9)
- Heavy-ion collision (6)
- COVID19-NMR (5)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Solution NMR spectroscopy (4)
- Solution NMR-spectroscopy (4)
- 5′-UTR (3)
- ALICE (3)
- Covid19-NMR (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- Non-structural protein (3)
- RNA (3)
- pp collisions (3)
- Beauty production (2)
- Charm physics (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- NMR spectroscopy (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Protein drugability (2)
- Psychiatric disorders (2)
- QCD (2)
- Single electrons (2)
- 19F (1)
- 2D NMR spectroscopy (1)
- 5'-UTR (1)
- 5_SL4 (1)
- 900 GeV (1)
- ALICE detector (1)
- Anti-nuclei (1)
- Boosted Jets (1)
- CD36 (1)
- CEST (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- COVID-19 (1)
- Cancer genomics (1)
- Centrality Class (1)
- Centrality Selection (1)
- Clinical genetics (1)
- Collective Flow, (1)
- Comparison with QCD (1)
- Covid19-nmr (1)
- DNA-PAINT (1)
- Decision Making und Risk (1)
- Dimerization domain (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- FBS (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Financial Markets (1)
- HBT (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Human behaviour (1)
- Inclusive spectra (1)
- Insurance (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- Macrodomain (1)
- Material budget (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Molecular neuroscience (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- NOESY (1)
- Neural network (1)
- Nuclear modification factor (1)
- Nucleic acid-binding domain (1)
- Nucleocapsid (1)
- Oncology (1)
- P2X7 receptor (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Personalized medicine (1)
- Predictive markers (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Protein druggability (1)
- Proton–proton (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RNA genome (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- Single muons (1)
- Structural protein (1)
- Systematic Uncertainty (1)
- TR (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Vector Boson Production (1)
- Xenon-based gas mixture (1)
- accessory proteins (1)
- balloon pulmonary angioplasty (1)
- calcium-independent phospholipase A2β (1)
- cell-free protein synthesis (1)
- chronic thromboembolic pulmonary hypertension (1)
- dE/dx (1)
- detector (1)
- exercise (1)
- experimental results (1)
- fluorine (1)
- fragment screening (1)
- fragment-based screening (1)
- heavy ion experiments (1)
- image-based risk modelling (1)
- inflammasome (1)
- interleukin-1β (1)
- intrinsically disordered region (1)
- machine learning (1)
- nonstructural proteins (1)
- personalised therapy (1)
- proteins (1)
- quark gluon plasma (1)
- radiation oncology (1)
- radiomic (1)
- right heart catheter (1)
- spectra (1)
- structural proteins (1)
- √sN N = 2.76 TeV (1)
Institute
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.
Epigenetic signatures such as methylation of the monoamine oxidase A (MAOA) gene have been found to be altered in panic disorder (PD). Hypothesizing temporal plasticity of epigenetic processes as a mechanism of successful fear extinction, the present psychotherapy-epigenetic study for we believe the first time investigated MAOA methylation changes during the course of exposure-based cognitive behavioral therapy (CBT) in PD. MAOA methylation was compared between N=28 female Caucasian PD patients (discovery sample) and N=28 age- and sex-matched healthy controls via direct sequencing of sodium bisulfite-treated DNA extracted from blood cells. MAOA methylation was furthermore analyzed at baseline (T0) and after a 6-week CBT (T1) in the discovery sample parallelized by a waiting time in healthy controls, as well as in an independent sample of female PD patients (N=20). Patients exhibited lower MAOA methylation than healthy controls (P<0.001), and baseline PD severity correlated negatively with MAOA methylation (P=0.01). In the discovery sample, MAOA methylation increased up to the level of healthy controls along with CBT response (number of panic attacks; T0–T1: +3.37±2.17%), while non-responders further decreased in methylation (−2.00±1.28%; P=0.001). In the replication sample, increases in MAOA methylation correlated with agoraphobic symptom reduction after CBT (P=0.02–0.03). The present results support previous evidence for MAOA hypomethylation as a PD risk marker and suggest reversibility of MAOA hypomethylation as a potential epigenetic correlate of response to CBT. The emerging notion of epigenetic signatures as a mechanism of action of psychotherapeutic interventions may promote epigenetic patterns as biomarkers of lasting extinction effects.